CHGCY (Chugai Pharmaceutical Co) Other Current Liabilities : $756 Mil (As of Dec. 2024)

View and export this data going back to 2008. Start your Free Trial

What is Chugai Pharmaceutical Co Other Current Liabilities?

Chugai Pharmaceutical Co's other current liabilities for the quarter that ended in Dec. 2024 was $756 Mil.

Chugai Pharmaceutical Co's quarterly other current liabilities declined from Jun. 2024 ($877 Mil) to Sep. 2024 ($752 Mil) but then increased from Sep. 2024 ($752 Mil) to Dec. 2024 ($756 Mil).

Chugai Pharmaceutical Co's annual other current liabilities increased from Dec. 2022 ($855 Mil) to Dec. 2023 ($937 Mil) but then declined from Dec. 2023 ($937 Mil) to Dec. 2024 ($756 Mil).

Chugai Pharmaceutical Co Other Current Liabilities Historical Data

The historical data trend for Chugai Pharmaceutical Co's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chugai Pharmaceutical Co Other Current Liabilities Chart

Chugai Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Current Liabilities

Get a 7-Day Free Trial

698.52

780.48

855.00

937.28

755.92

Chugai Pharmaceutical Co Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Other Current Liabilities	Get a 7-Day Free Trial															937.28	808.78	877.34	751.97	755.92

Chugai Pharmaceutical Co Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

Chugai Pharmaceutical Co Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Chugai Pharmaceutical Co's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Chugai Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chugai Pharmaceutical Co Ltd (OTCPK:CHGCY) » Definitions » Other Current Liabilities

Comparable Companies

Traded in Other Exchanges

CHGCF:USA 4519N:Mexico 4519:Japan CUP:Germany

Address

1-1 Nihonbashi-Muromachi 2-Chome, Nihonbashi Mitsui Tower (Reception15F), Chuo-ku, Tokyo, JPN, 103-8324

Website

http://www.chugai-pharm.co.jp

Chugai Pharmaceutical is a Japanese drug developer and subsidiary of Roche Holding, which owns roughly 60% of the company. Founded in 1925, Chugai deals primarily in the Japanese market, where it generates roughly half of its revenue. It has been the leader in Japan's oncology market for the past decade, largely due to drugs licensed from its parent's portfolio. The company also develops its own innovative medicines. It is an industry leader in antibody technology with several flagship therapies, including Hemlibra for hemophilia A patients and Actemra for treating rheumatoid arthritis and covid patients.